Why Clarivate’s New AI Platform Matters for the Stock

Clarivate (CLVT) has launched Web of Science Research Intelligence, an AI-native platform built with research institutions to combine curated data, impact metrics, and workflows across funding, collaboration, and research assessment.

For shareholders, this fresh product sits at the heart of Clarivate’s existing research and intellectual property data assets, raising questions about adoption, pricing power, and how it may influence sentiment around a stock that has faced mixed recent returns.

Despite the product launch, Clarivate’s short term share price performance has been choppy. The 7 day share price return is down 12.95% and the year to date share price return is down 25.31%, while the 90 day share price return is up 33.70% and the 1 year total shareholder return is down 43.72%. This points to recent momentum after a much tougher multi year stretch for investors.

If you are looking beyond Clarivate and want to see where AI driven growth stories are emerging across the market, take a look at 62 profitable AI stocks that aren't just burning cash

With the stock trading at US$2.42, showing a mixed track record of returns and sitting at a discount to analyst targets and some intrinsic estimates, is there still a mispriced opportunity here, or is the market already baking in the AI upside?

Most Popular Narrative: 42.5% Undervalued

According to the most followed narrative on Clarivate, a fair value of $4.21 sits well above the last close at $2.42, framing the stock as materially discounted.

Clarivate operates behind the scenes, but its influence shapes outcomes across innovation, law, and research. Intellectual property has become too important to manage informally. Data-driven insight is now a requirement, not a luxury.

Want to see what justifies that gap between price and fair value? The narrative leans on steady revenue, improving margins, and a profitability path that reshapes how the market could view this business.

Result: Fair Value of $4.21 (UNDERVALUED)

However, this hinges on Clarivate converting its revenue base of US$2,447.0 million and an annual net loss of US$137.4 million into sustained, cleaner profitability.

Next Steps

Given the mix of concern and optimism in this story, it helps to look at the underlying data yourself, compare the upside and downside, and weigh the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop with just one stock, you might miss out on better fits for your goals. Put a few fresh ideas side by side and compare.

• Target resilient cash generators by scanning companies that show strong fundamentals through the solid balance sheet and fundamentals stocks screener (45 results).
• Hunt for quality at a discount with the 50 high quality undervalued stocks and see which stocks trade below their implied worth.
• Spot early stage potential by checking the 25 elite penny stocks with strong financials and review which smaller companies still offer room to grow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.